Alexandria Real Estate Equities, Inc. has a market capitalization of $8.82B and is currently priced at $51.76, down 1.18% from the previous close of $52.38. The stock's day range has fluctuated between $51 and $52.96. Over the last year, the company's EPS has seen a significant decline of 568.89%, while its return on equity (ROE) stands at -9.24% and the debt-to-equity (D/E) ratio is 0.80.
Investors may want to consider the significant fluctuations in EPS and ROE when evaluating Alexandria Real Estate Equities, Inc.
Some investors argue that Alexandria Real Estate Equities, Inc. is well-positioned within the life sciences sector, being recognized as the second most active early-stage life science investor in New York City. Additionally, the company was named among the top 20 for talent readiness by The Wall Street Journal, which could enhance its operational performance.
Conversely, the substantial decline in EPS of 568.89% year-over-year raises concerns about profitability, while a negative ROE of -9.24% indicates potential inefficiencies in generating returns for shareholders. The current stock price also reflects a negative change of 1.18%, which may signal investor skepticism.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Alexandria Real Estate Equities, Inc. has a market capitalization of $8.82B and is currently priced at $51.76, down 1.18% from the previous close of $52.38. The stock's day range has fluctuated between $51 and $52.96. Over the last year, the company's EPS has seen a significant decline of 568.89%, while its return on equity (ROE) stands at -9.24% and the debt-to-equity (D/E) ratio is 0.80.
Conversely, the substantial decline in EPS of 568.89% year-over-year raises concerns about profitability, while a negative ROE of -9.24% indicates potential inefficiencies in generating returns for shareholders. The current stock price also reflects a negative change of 1.18%, which may signal investor skepticism.
Some investors argue that Alexandria Real Estate Equities, Inc. is well-positioned within the life sciences sector, being recognized as the second most active early-stage life science investor in New York City. Additionally, the company was named among the top 20 for talent readiness by The Wall Street Journal, which could enhance its operational performance.
Some investors argue that Alexandria Real Estate Equities, Inc. is well-positioned within the life sciences sector, being recognized as the second most active early-stage life science investor in New York City. Additionally, the company was named among the top 20 for talent readiness by The Wall Street Journal, which could enhance its operational performance. Conversely, the substantial decline in EPS of 568.89% year-over-year raises concerns about profitability, while a negative ROE of -9.24% indicates potential inefficiencies in generating returns for shareholders. The current stock price also reflects a negative change of 1.18%, which may signal investor skepticism.
Alexandria Real Estate Equities, Inc. has a market capitalization of $8.82B and is currently priced at $51.76, down 1.18% from the previous close of $52.38. The stock's day range has fluctuated between $51 and $52.96. Over the last year, the company's EPS has seen a significant decline of 568.89%, while its return on equity (ROE) stands at -9.24% and the debt-to-equity (D/E) ratio is 0.80.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for ARE at helmterminal.dev/analyze/ARE, updated continuously during US market hours. No signup required.